Source:http://linkedlifedata.com/resource/lhgdn/association:4544
| Subject | Predicate | Object | Context |
|---|---|---|---|
| lhgdn:association:4544 | lhgdn:found_in | pubmed-article:17492760 | lld:lhgdn |
| lhgdn:association:4544 | lhgdn:geneRifSource | a carrier of the founder CDKN2A [p.Leu113Leu; p.Pro114Ser]mutation as well as two MC1R moderate-risk variants, [p.Arg151Cys (+) p.Arg163Gln]developed 22 primary melanomas in the 3 years that followed initiation of levodopa therapy for Parkinson?s disease | lld:lhgdn |
| lhgdn:association:4544 | lhgdn:mesh_code | D008545 | lld:lhgdn |
| lhgdn:association:4544 | lhgdn:associationIdType | http://http://linkedlifedat... | lld:lhgdn |
| lhgdn:association:4544 | lhgdn:umls_code | umls-concept:C0025202 | lld:mappings |
| entrez-gene:1029 | lhgdn:associationId | lhgdn:association:4544 | lld:lhgdn |